Author

Betül Haykir

Boston Children's Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

David T. BreaultiD· 2 shared Diana L. CarloneiD· 2 shared Felix BeuschleiniD· 2 shared Kleiton Silva BorgesiD· 2 shared Mesut BerberiD· 2 shared Vasileios ChortisiD· 2 shared Alcides Euzebio Tavares XavieriD· 1 shared Alessandro PreteiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

David T. BreaultORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyJournal of Clinical InvestigationPeer-reviewedJan 27, 2026

Rho-ROCK signaling and α-Catenin mediate β-Catenin-driven hyperplasia in the adrenal via adherens junctions

Mesut Berber, Betül Haykir, Nick A. Guagliardo…·David T. Breault

This study shows that β-Catenin-driven hyperplasia in the adrenal cortex is mediated through Rho-ROCK signaling and Cat-dependent stabilization of adherens junctions.

3 citationstop 2%

mousehuman

𝕏 PostBluesky

Cancer BiologybioRxivPreprintSep 28, 2025

Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesis

Vasileios Chortis, Kleiton Silva Borges, Cong-Hui Yao…·David T. Breault

This study identifies glutamine antagonism as a therapeutic strategy for adrenocortical carcinoma by inhibiting de novo nucleotide biosynthesis and inducing DNA damage.

1 citation

humanmouse

𝕏 PostBluesky